Back
Role of Serum Procalcitonin Level in Differentiating between Pulmonary Tuberculosis and Community-Acquired Pneumonia
Mohammad Shameem, Mazhar Alam, Shagufta Moin, Rakesh Bhargava, Zuber Ahmad, Jamal Akhtar
Int. J. Clin. Med. Vol.5 No.15, August 07, 2014  DOI: 10.4236/ijcm.2014.515121
       (PDF  1407K)     HTML      XML
Comparative efficacy of levofloxacin and ceftriaxone in the treatment of community acquired pneumonia in children
Mujibul Hoque, Mohammad Nuruzzaman, Md. Abdul Malik
Open J. Pediatr. Vol.3 No.3, August 27, 2013  DOI: 10.4236/ojped.2013.33046
       (PDF  149K)     HTML     
Clinical Profile and Outcome of Acute Kidney Injury in Elderly Adults in a Tertiary Hospital in Cameroon
Fouda Menye Epse Ebana Hermine Danielle, Ladze Clavis Berinyuy, Mahamat Maimouna, Nzana Victorine Bandolo, Ndjong Emmanuel, Kaze Folefack Francois
Open J. Nephrol. Vol.10 No.4, November 04, 2020  DOI: 10.4236/ojneph.2020.104031
       (PDF  573K)     HTML      XML
Corticosteroids and ICU Course of Community Acquired Pneumonia in Egyptian Settings
Nirmeen A. Sabry, Emad El-Din Omar
Pharmacol. Pharm. Vol.2 No.2, March 30, 2011  DOI: 10.4236/pp.2011.22009
       (PDF  220K)     HTML     
Clinical Utility of Procalcitonin for Differentiating between Cryptogenic Organizing Pneumonia and Community-Acquired Pneumonia
Satoshi Takeda, Nobuhiko Nagata, Hiroyuki Miyazaki, Takanori Akagi, Taishi Harada, Masaru Kodama, Shinichiro Ushijima, Takashi Aoyama, Kentaro Wakamatsu, Masaki Fujita, Kentaro Watanabe
Int. J. Clin. Med. Vol.6 No.6, June 04, 2015  DOI: 10.4236/ijcm.2015.66048
       (PDF  353K)     HTML      XML
 
 
Top